Discovery of Novel Autotaxin Inhibitors Bearing the 4,5,6,7‐Tetrahydro‐7 H ‐Pyrazolo[3,4‐ c ]Pyridine‐7‐One Core for Pulmonary Fibrosis Therapy
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.70095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Jiahe Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, People's Republic o…. Hauptthemen laut MEDLINE: Phosphoric Diester Hydrolases, Pulmonary Fibrosis, Drug Discovery, Pyrazoles. Die Arbeit nennt 21 Literaturangaben. Gefördert von: This study was supported by China Postdoctoral Science Foundation under Grant Number (2024M762164)..
Abstract (Originalsprache)
Pulmonary fibrosis (PF) is a progressive and fatal disease, and recent studies have revealed its key role in the autotaxin (ATX)‐lysophosphatidic acid (LPA) signaling pathway, revealing the therapeutic potential of targeting ATX. Herein, starting from PAT‐409, a series of novel ATX inhibitors containing the 4,5,6,7‐tetrahydro‐7 H ‐pyrazolo[3,4‐ c ]pyridin‐7‐one core were designed to improve the pharmacological activity and physicochemical properties. The most promising compound 19 exhibited potent ATX inhibition (IC 50 = 4.2 nM) and significantly reduced lipophilicity (cLogP = 2.992) compared with PAT‐409 (IC 50 = 4.9 nM, cLogP = 7.647). Molecular dynamics simulations indicated that 19 bound to the ATX protein in a highly stable manner. Furthermore, predictive analyses of drug‐like properties and toxicity uncovered that 19 demonstrated comparable safety to PAT‐409 while exhibiting significantly superior drug‐like characteristics. This study provides a promising ATX inhibitor for PF therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, People's Republic of China.
Förderung
- This study was supported by China Postdoctoral Science Foundation under Grant Number (2024M762164).
Zitieren
APA
Zhang, J., Zhang, J., Li, J., Ma, D., Tan, Z., & Zhai, X. (2025). Discovery of Novel Autotaxin Inhibitors Bearing the 4,5,6,7‐Tetrahydro‐7 H ‐Pyrazolo[3,4‐ c ]Pyridine‐7‐One Core for Pulmonary Fibrosis Therapy. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70095
Vancouver
Zhang J, Zhang J, Li J, Ma D, Tan Z, Zhai X. Discovery of Novel Autotaxin Inhibitors Bearing the 4,5,6,7‐Tetrahydro‐7 H ‐Pyrazolo[3,4‐ c ]Pyridine‐7‐One Core for Pulmonary Fibrosis Therapy. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70095
BibTeX
@article{Zhang2025,
author = {Zhang, Jiahe and Zhang, Jiachen and Li, Jiandong and Ma, Deyi and Tan, Zehui and Zhai, Xin},
title = {Discovery of Novel Autotaxin Inhibitors Bearing the 4,5,6,7‐Tetrahydro‐7 H ‐Pyrazolo[3,4‐ c ]Pyridine‐7‐One Core for Pulmonary Fibrosis Therapy},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.70095}
}
EUVIMED